Platelet function recovery after cessation of aspirin: Preliminary study of volunteers and surgical patients

European Journal of Anaesthesiology

Volumn 27, Issue 7, 2010, Pages 617-623

  Zisman, Eliyahu ^a   Erport, Angelika ^a   Kohanovsky, Eugene ^a   Ballagulah, Marc ^a   Cassel, Aliza ^b   Quitt, Miriam ^b   Pizov, Reuven ^a  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Aspirin; Platelet aggregometry; Platelets; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID; FIBRINOGEN; HEMOGLOBIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLEEDING; DRUG URINE LEVEL; DYSPNEA; ELECTIVE SURGERY; FEMALE; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; SKIN BRUISING; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; WHEEZING;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ARACHIDONIC ACID; ASPIRIN; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; EPINEPHRINE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PILOT PROJECTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SURGICAL PROCEDURES, ELECTIVE; THROMBOXANE B2; TIME FACTORS; YOUNG ADULT;

EID: 77953786872     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328335b354     Document Type: Article

References (42)

1. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69:1366-1372.
2. Fitzgerald GA, Oates JA, Hawiger J, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983; 71:676-688.
3. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and the risk of peptic ulcer bleeding. BMJ 1995; 310:827-830.
4. Kelly JP, Kaufman DW, Jurgelon JM, et al. Risk of aspirin associated major upper gastrointestinal bleeding with enteric coated or buffered product. Lancet 1996; 348:1413-1416.
5. Amin AR, Attur MG, Pillinger M, Abramson SB. The pleiotropic functions of aspirin: mechanisms of action. Cell Mol Life Sci 1999; 56:305-312.
6. Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1997; 96:2751-2753.
7. Vane J. Towards the better aspirin. Nature 1994; 367:215-216.
8. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998; 280:1930-1935.
9. Scher KS. Unplanned reoperation for bleeding. Am Surg 1996; 62:52-55.
10. Connly CS, Panush RS. Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch Intern Med 1991; 151:1963-1966.
11. Watson CJE, Deane AM, Doyle PT, Bullock KN. Identifiable factors in postprostatectomy haemorrhage: the role of aspirin. Br J Urol 1990; 66:85-87.
12. Neilipovitz DT, Bryson GC, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93:573-580.
13. Taggart DP, Siddiqui A, Wheatley DJ. Low dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990; 50:425-428.
14. Gibbs NM, Weightman WM, Thackray NM, et al. The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15:55-59.
15. Sonksen JR, Kong KL, Holder R. Magnitude and time course of impaired primary hemostasis after stopping low and medium dose aspirin in healthy volunteers. Br J Anaesth 1999; 82:360-365.
16. Coleman JL, Alberts MJ. Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers. Am J Cardiol 2006; 98:838-841.
17. Bick RL. Platelet function defects: a clinical review. Semin Thromb Hemost 1992; 18:167-185.
18. Riddell JW, Chiche L, Plaud B, Hamon M. Coronary stents and noncardiac surgery. Circulation 2007; 116:e378-e382.
19. Mangano DT, Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347:1309-1317.
20. Ghooi RB, Thatte SM, Joshi PS. The mechanism of action of aspirin: is there anything beyond cyclooxygenase? Med Hypotheses 1995; 44:77-80.
21. Alberts MJ, Bergman DL, Molner E, et al. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 2004; 35:175-178.
22. Ferrell TP, Hayes KB, Sobel BE, Schneider DJ. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine. Am J Cardiol 1999; 83:770-774.
23. Derry S, Loke YK. Risk of gastrointestinal hemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321:1183-1187.
24. Weber AA, Leisener S, Hohlfeld T, Schror K. 40mg aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. Thromb Res 2000; 97:365-367.
25. Heyns AP. Thrombopoiesis and platelet kinetics, hemostasis and thrombosis. In: Bloom AL, Forbs CD, Thomas DP, Toddenham EGD, editors. Edinburgh: Churchill-Livingstone; 1994. pp. 31-44.
26. Fogari R, Zoppi A. Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant? Am J Cardiovasc Drugs 2005; 5:211-223.
27. Schafer A, Fraccarollo D, Hildemann S, et al. Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition. Thromb Haemost 2003; 89:1024-1030.
28. Kishi Y, Ohta S, Kasuya N, et al. Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial antiplatelet function in human umbilical vein endothelial cells. J Hypertens 2003; 21:1347-1353.
29. Wenaweser P, Windecker S, Billinger M, et al. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis. Am J Cardiol 2007; 99:353-356.
30. Boushra NN, Muntazar M. Review article: the role of statins in reducing perioperative cardiac risk - physiologic and clinical perspectives. Can J Anaesth 2006; 53:1126-1147.
31. Ferroni P, Basili S, Santilli F, Davi G. Low-density lipoprotein-lowering medication and platelet function. Pathophysiol Haemost Thromb 2006; 35:346-354.
32. Feher G, Koltai K, Papp E, et al. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables. Drugs Aging 2006; 23:559-567.
33. Sudic D, Razmara M, Forslund M, et al. High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Haematol 2006; 133:315-322.
34. Takahashi S, Ushida M, Komine R, et al. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thromb Res 2007; 119:517-524.
35. Miersch S, Sliskovic I, Raturi A, Mutus B. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes. Free Radic Biol Med 2007; 42:270-279.
36. Faraday N, Becker DM, Becker LC. Pharmacogenomics of platelet responsiveness to aspirin. Pharmacogenomics 2007; 8:1413-1425.
37. Rosin C, Brunner M, Lehr S, et al. The formation of platelet-leukocyte aggregates varies during the menstrual cycle. Platelets 2006; 17:61-66.
38. Boudoulas KD, Montague CR, Goldschmidt-Clermont PJ, Cooke GE. Estradiol increases platelet aggregation in Pl(A1/A1) individuals. Am Heart J 2006; 152:136-139.
39. Akarasereenont P, Tripatara P, Chotewuttakorn S, et al. The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate. Platelets 2006; 17:441-447.
40. Becker DM, Segal J, Vaidya D, et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 2006; 295:1420-1427.
41. Picker SM, Kaleta T, Hekmat K, et al. Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome. Eur J Anaesthesiol 2007; 24:332-339.
42. Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62:1217-1220.